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Abstract
Background: Methotrexate (MTX) has been shown to affect the testes adversely,
especially the seminiferous epithelium. Asmelatonin, an endocrine hormone, has been
shown to normalize testicular function, its ability to prevent MTX-induced testicular
damage should be considered.
Objective: Based on the antioxidant, anti-inflammatory, and antiapoptotic activities of
melatonin, this study aimed to investigate its protective effect against testicular damage
induced by MTX.
Materials and Methods: Forty adult male rats (200-230 g) were divided into five
groups (n = 8/each). The rats in group I were injected with vehicle as a control. In
group II, the rats were received intraperitoneal injections of melatonin (8 mg/kg) for
15 consecutive days. The rats in group III were intravenously injected with MTX (75
mg/kg) for 15 consecutive days. The remaining two groups received melatonin (8
mg/kgBW) for 15 (group IV) and 30 (group V) consecutive days, intraperitoneally, and
then intravenously received MTX (75 mg/kgBW) on days 8 and 15 of the experimental
period. Reproductive parameters, including epididymal sperm concentration, testicular
tyrosine-phosphorylated protein expression, steroidogenic acute regulatory (StAR)
protein expression, and caspase-3 and malondialdehyde levels, were examined.
Results: The sperm concentrations (×106/ml) of groups IV (58.75 ± 1.28) and V (55.93
± 2.57) were improved significantly (p = 0.032) compared with that of group II (32.92 ±
2.14). The seminiferous epithelium in groups IV and V also increased, while caspase-
3 expression decreased. In the melatonin-treated groups, the expression of tyrosine-
phosphorylated proteins at 32 kDa was decreased and that of proteins at 47 kDa was
increased compared with the MTX group. StAR protein expression was not altered in
any of the groups.
Conclusion: Our results indicate that melatonin improves the epididymal sperm
concentration by decreasing the expression of caspase-3 and increasing that of
tyrosine-phosphorylated proteins in MTX-treated testes.
Key words: Melatonin, Testis, Sperm, Methotrexate, Caspase-3, Tyrosine
phosphorylation.
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1. Introduction
Many reports have demonstrated that drugs
used for chemotherapy have side effects on
several organs, including those of the reproductive
system (1, 2). In the male reproductive system,
some chemotherapeutic agents have been
reported to cause azoospermia, testicular
damage, sex hormone dysfunction, and infertility
in human and animal models due to their anti-
cell division and antiproliferative activity (3, 4).
Methotrexate (MTX), a folic acid antagonist, is
used widely to treat various neoplastic and
non-malignant diseases, such as rheumatoid
arthritis, psoriasis, graft-versus-host disease,
multiple sclerosis, and keratoacanthomas (5,
6). However, MTX has been reported to have
negative side effects on the male reproductive
system (7-9). Previous studies have indicated that
MTX causes disorganization and vacuolization of
the seminiferous epithelium, decreased sperm
count, damaged sperm DNA, and decreased
testicular weight as well as the seminal vesicle
and prostate gland (10-12). Moreover, MTX
causes an increase in the number of apoptotic
cells and the oxidative stress in the testes (9,
13). Recently, MTX was shown to affect the
expression of testicular functional proteins, such
as tyrosine-phosphorylated and steroidogenic
acute regulatory (StAR) proteins (14). Moreover,
MTX may induce testicular germ cell apoptosis
by increasing the apoptotic index and the mRNA
expression of caspase-3, caspase-8, and caspase-
9 (8, 15). Further, the adverse effects of MTX
have been associated with an increase in reactive
oxygen species (ROS) in the testes (15). Numerous
reports have also found increased levels of
malondialdehyde (MDA) and low superoxide
dismutase (SOD) and catalase (CAT) activity in
the testicular tissue of MTX-treated animals (15,
16).
Melatonin is an endocrine hormone produced
by the pineal gland to regulate normal
testicular function through the hypothalamic-
adenohypophyseal axis (17, 18). Additionally,
melatonin has been shown to have anti-
inflammatory and proliferative effects (18, 19).
Moreover, it has been demonstrated to reduce
the expression of caspase-3 in ovaries and testes
damaged by chemotherapeutic drugs (20-23).
Based on the antioxidant, anti-inflammatory, and
antiapoptotic activities of melatonin, the present
study aimed to investigate its protective effect
against testicular damage induced by MTX.
2. Materials and Methods
2.1. Animals and experiment design
The male reproductive organs of rats were
obtained from a research project led by associate
professor, Dr. Jariya Umka Welbat (Department
of Anatomy, Faculty of Medicine, Khon Kaen
University). The research was approved by the
Animal Ethics Committee of Khon Kaen University,
based on the Ethics of Animal Experimentation
of Thailand (Record No. ACU-KKU-46/2559).
Briefly, the 40 adult male Sprague-Dawley rats
(200-230 g) were purchased from the National
Laboratory Animal Center (Salaya, Nakhon Pathom,
Thailand). The animals were housed under
standard conditions in the North-East Laboratory
Animal Center at Khon Kaen University in Thailand.
The rats were divided into five groups (n = 8/each):
• Group I (control group) received an ethanol
and normal saline solution similar to the treated
groups.
• Group II (melatonin-treated group)
received intraperitoneal injections of melatonin
(Sigma-Aldrich, Inc., St. Louis, MO, USA)
at a dose of 8 mg/kg for 15 consecutive
days.
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• Group III (MTX group) were intravenously
injected with 0.5 ml/kg MTX (Pharmachemie B.V.,
Harsblem, the Netherlands) at a dose of 75
mg/kg on days 8 and 15 of the experiment.
They were also intraperitoneally injected with
leucovorin (Ben Venue Laboratories, Inc., Bedford,
MA, USA) at a volume of 1 ml/kg (at a dose of
6 mg/kg) 18, 26, 42, and 50 hour after the MTX
injections,
• Group IV were intraperitoneally injected with
melatonin (8 mg/kg) for 15 consecutive days
and MTX (75 mg/kg) on days 8 and 15 of the
experimental period.
• Group V were intraperitoneally injected with
melatonin (8 mg/kg) for 30 consecutive days
and MTX (75 mg/kg) on days 8 and 15 of the
experimental period.
Melatonin was freshly prepared by dissolution
in ethanol and dilution with 0.9% normal saline
solution. At the end of the experiment, animals
were euthanized by rapid stunning and cervical
dislocation as described previously (24).
2.2. Histological examination of male
reproductive organs and sperm
concentration
At the end of the experiment, the testes,
epididymis plus vas deferens, and seminal vesicle
plus prostate glandwere collected, and the fat pads
surrounding the organs were removed gently. The
left testis and epididymis plus vas deferens were
then fixed rapidly in 10% formalin and processed
for paraffinization before being sectioned at 5-
𝜇m thickness. All tissue sections were stained
with hematoxylin and eosin dyes. The histology
of the testis and epididymis was observed and
captured by a Nikon ECLIPSE E200 microscope
equipped with a DXM1200 digital camera. For
seminiferous tubule (ST) diameter measurement,
the diameters of 10 randomly selected ST cross-
sections from each animal were measured. Each
selected ST was measured for the distance
from the basement membrane to the opposite
basement membrane in four planes using the
ImageJ 1.52a program (4). The sperm mass
and fluid from the right cauda epididymis and
vas deferens were squeezed and dipped into
1 ml phosphate-buffered saline (PBS; pH 7.4).
Subsequently, the sperm suspension was diluted
(1:10), loaded onto a hemocytometer, and counted
under a microscope. The sperm concentration




The paraffinized testicular blocks were
sectioned to 5 𝜇m using a rotary microtome (Leica
RM2235) in a preclinic building at the School
of Medicine of Mae Fah Luang University. The
testicular sections were placed on gelatin-coated
glass slides and warmed in a hot air oven (55-
60°C). The sections were then deparaffinized with
xylene and rehydrated with serial alcohols. In the
antigen retrieval step, the sections were soaked
twice and immersed in citrate buffer (10 mM citric
acid, 0.05% Tween-20, pH 6.0) in a microwave at a
high temperature (800 W) for 5 min. After washing
the citrate buffer, the sections were then blocked
for non-specific proteins by incubation with 5%
bovine serum albumin (BSA) in PBS (pH 7.4) for
20 min in a moist chamber in darkness. To detect
caspase-3 protein, all sections were incubated with
monoclonal anti-caspase-3 antibody (Santa Cruz
Biotechnology) diluted with PBS (1:50) in a moist
chamber at 4°C overnight. Then, the non-specific
binding antibodies in all sections were washed
out with PBS and incubated with anti-mouse IgG𝜅
light chain-binding protein (m-IgG𝜅 BP) conjugated
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with fluorescein isothiocyanate (FITC; 1:50; Santa
Cruz Biotechnology) in a moist chamber for 1 h at
room temperature. Finally, the caspase-3 protein-
antibody complexes were detected on each
section by FITC luminescence emission under a
Carl Zeiss fluorescence microscope (AxioScope;
Rushmore Precision Co., Ltd., city, state code,
country) via the ZEN 2.3 (blue edition) program.
The caspase-3 complex gave a green fluorescence
positive signal.
2.4. Western blot analysis
The testicular protein samples were extracted
with radioimmunoprecipitation (RIPA) buffer (Cell
Signaling Technology, Inc., city, state code, USA)
containing a protease inhibitor cocktail (Sigma-
Aldrich, Inc.). The supernatant testicular lysate was
thenmeasured for total protein concentration using
a NanoDrop ND-1000 Spectrophotometer (Nano
Drop Technology, Inc., city, state code, USA) at
an absorbance of 280 nm in the Vejawichakarn
building of the Faculty of Medicine at Khon Kaen
University. The testicular protein profile (80 µg) was
separated on 12% separating gel (SDS-PAGE).
The separated proteins were transferred onto
a nitrocellulose membrane (Bio-Red Laboratories,
Inc., city, Germany) in a 10% methanol transfer
buffer. Subsequently, the non-specific proteins
were blocked with 5% skim milk. To examine the
expression of tyrosine-phosphorylated protein,
StAR protein, and caspase-3, the membrane was
incubated with monoclonal anti-phosphotyrosine
4G10 antibody (1:1000; Millipore, city, state code,
country), polyclonal anti-StAR antibody (1:2000;
Santa Cruz Biotechnology), or monoclonal
anti-caspase-3 antibody (1:100; Santa Cruz
Biotechnology) at 4°C overnight. The membrane
was also incubated with monoclonal anti-𝛽-actin
antibody as an internal control (1:1000; Santa Cruz
Biotechnology).
Each of the non-binding antibodies was washed
out of the membrane, and the membrane was
further incubated with a non-binding antigen-
antibody complex for each antibody. The
complexes were composed of specific secondary
antibodies conjugated to the primary antibodies
with horseradish peroxidase at room temperature.
After washing, each non-binding antigen-antibody
complex was incubated with an enhanced
chemiluminescence substrate kit reagent (GH
Healthcare Life Science). The positive protein
bands were detected using the ImageQuant LAS
500 imaging system (GH Healthcare Life Science)
in the Vejawichakarn building of the Faculty of
Medicine at Khon Kaen University in Thailand.
To quantify the level of target protein expression,
the intensities of protein bands were measured
using the Image J 1.52a program. In this study,
BSA (Millipore), epidermal growth factor (Millipore),
and StAR lysate (Santa Cruz Biotechnology) were
used as specific negative and positive controls of
tyrosine-phosphorylated protein and StAR protein,
respectively (4).
2.5. MDA examination
The testicular protein was extracted using RIPA
buffer (Cell Signaling Technology, Inc.) containing
a protease inhibitor cocktail (Sigma-Aldrich, Inc.).
The testicular tissue was then homogenized using
a glass grinder and an ultrasonic homogenizer
(Cole-Parmer, 04714-53, Vernon Hills, IL, USA;
microprocessor-controlled 100-W model). To
separate the testicular supernatant from cell debris,
the tissue homogenate was ultracentrifuged at
14,000 rpm. The supernatants were thenmeasured
for total protein concentration using the NanoDrop
spectrophotometer. Subsequently, the MDA
level in the supernatant was measured using
the thiobarbituric acid reactive substance assay
as explained previously (4). Briefly, the principle
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of the assay is to detect the reaction between
testicular MDA molecules and thiobarbituric acid,
the product of which turns into a pink chromogenic
compound that can be measured at an absorbance
of 540 nm (Sunrise absorbance reader, Tecan,
Männedorf, Switzerland). The testicular MDA levels
were expressed as nmol of MDA/mg of testicular
protein.
2.6. Ethical consideration
This research was approved by Animal Ethics
Committee of Khon Kaen University, based on
the Ethics of Animal Experimentation of National
Research Council of Thailand (Record No. ACU-
KKU-46/2559, Ref. No. 0514.1.75/51)
2.7. Statistical analysis
The data analysis was carried out using the
Statistical Package for the Social Sciences (SPSS
software, Chicago, Illinois), version 22.0. To
determine the significant differences between
groups, One-way analysis of variance and Student’s
t tests were used. P-value < 0.05 was considered
statistically significant.
3. Results
3.1. Effects of melatonin on the body
weight and reproductive parameters
of male rats treated with MTX
The results revealed no significant difference
in body weight among groups (Table I). However,
the weights of the testes and epididymis plus vas
deferens of the melatonin group were higher than
those of the MTX group. Compared with the control
and melatonin groups, the sperm concentration
in the MTX group was also low (Table I). The
preventive (IV and V) and melatonin groups both
showed improvements in the epididymal sperm
concentration comparedwith theMTXgroup (Table
I). Moreover, in comparison with theMTX group, the
ST diameter of the melatonin group was improved
significantly (Table I).
3.2. Effects of melatonin on the
histology of the testes and cauda
epididymis in the MTX group
The results revealed that the melatonin did not
had a significant effect on the histology of the
testes and cauda epididymis in the MTX group
compared with the control. However, reductions
in the seminiferous epithelium (Table I) and
epididymal sperm mass were observed in the MTX
group. Additionally, the MTX group showed wide
interstitial spaces compared with the control group.
Both the preventive (IV and V) and melatonin
groups showed normal seminiferous epithelium
compared with the control and melatonin groups.
No differences in epididymal histology were found
among any of the groups.
3.3. Effects of melatonin and MTX
on testicular tyrosine-phosphorylated
protein
The graph presented in Figure 1A reveals
that the total protein profiles in the testicular
lysate were similar among all groups. In addition,
the patterns of tyrosine-phosphorylated protein
expression among the control and treated groups
were all similar and included expressions at 31, 32,
36, 42, 47, 54, 58, 72, and 82 kDa (Figure 1B).
However, the intensity of expression at 31 and 32
kDa in the MTX group was significantly higher than
that in the control group (Figure 1C). Further, the
expressions at 32 and 47 kDa in the preventive
groups (IV and V) were significantly increased and
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decreased compared with those in the MTX group,
respectively (Figure 1C).
3.4. Effects of melatonin on testicular
StAR protein expression in rats treated
with MTX
Western blot revealed that the StAR protein was
expressed in the testicular lysate of all groups
(Figure 2A). Using 𝛽-actin as an internal control, it
was revealed that the intensity of testicular StAR
protein expression was not significantly different
among the groups (Figure 2B).
3.5. Effects of melatonin and MTX on
testicular caspase-3
The immunofluorescent staining results for
caspase-3 revealed that the protein was localized
in both the seminiferous epithelium and interstitial
tissues of all groups (Figure 3A). This finding was
also confirmed by western blotting (Figure 3B).
However, the intensity of caspase-3 expression
was much greater in all the treated groups than in
the control group (Figure 3A). Figures 3B and 5C
further revealed that the expression of caspase-3
in the MTX group was increased compared with
that in the other groups. The intensity of caspase-3
expression was also lower in the preventive (IV
and V) groups than in the MTX group (Figure 3C).
3.6. Effects of melatonin on testicular
MDA levels in rats treated with MTX
Figure 4 shows a comparison of the testicular
MDA levels among the control and treated
groups. The results revealed that the MTX group
underwent a significant increase in MDA level in
the testicular lysate compared with the control and
melatonin groups. Moreover, the MDA levels of the
preventive and melatonin groups were significantly
increased compared with that of the MTX group
(Figure 4).
Table I. The body weight and reproductive parameters in the study groups (n = 8/each)
Parameters Group I Group II Group III Group IV Group V
Body weight (g) 409 ± 6 399 ± 6 408 ± 6 393 ± 7 372 ± 5
Testes
Absolute weight (g) 1.85 ± 0.03 1.88 ± 0.02 1.70 ± 0.04𝑎 1.72 ± 0.06 1.81 ± 0.03
Relative weight (g 100 g−1) 0.45 ± 0.01 0.46 ± 0.01 0.43 ± 0.01 0.44 ± 0.01 0.49 ± 0.01𝑏
Epididymis plus vas deferens
Absolute weight (g) 0.65 ± 0.02 0.61 ± 0.01 0.62 ± 0.01 0.60 ± 0.03 0.62 ± 0.02
Relative weight (g 100 g−1) 0.16 ± 0.004 0.15 ± 0.002 0.16 ± 0.004 0.15 ± 0.008 0.17 ± 0.003𝑏
Seminal vesicle and prostate gland
Absolute weight (g) 2.04 ± 0.05 1.95 ± 0.06 1.87 ± 0.05 1.83 ± 0.07 1.68 ± 0.10
Relative weight (g 100 g−1) 0.50 ± 0.01 0.48 ± 0.02 0.47 ± 0.01 0.47 ± 0.01 0.45 ± 0.02
Sperm concentration (×106 cells mL−1) 77.44 ± 1.97 59.67 ± 2.17𝑎 32.92 ± 2.14𝑎,𝑐 58.75 ± 1.28𝑏 55.93 ± 2.57𝑏
Seminiferous tubular diameter (𝜇m) 253.96 ± 3.10 255.98 ± 3.89 221.89 ± 3.57𝑎 224.55 ± 1.94 239.33 ± 2.42𝑏
All data presented as Means ± SEM. a: p < 0.05 (compared with the control group), b: p < 0.05 (compared with the MTX group),
c: p < 0.05 (compared with the melatonin group)
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Figure 1. (A) SDS-PAGE showing the total testicular protein profiles. (B) Immuno-western blotting of tyrosine-phosphorylated
proteins in testicular lysate. (C) The intensity of protein expression in the control and treated groups. PMs, pre-stained markers;
EGF, epididymal growth factor (used as a positive control); a: p < 0.05 (compared with the control group); b: p < 0.05 (compared
with the MTX group).
Figure 2. (A) Immuno-western blotting of StAR proteins in testicular lysate. (B) The ratio of StAR/𝛽-actin in the control (I) and treated
(II-V) groups. PMs, pre-stained markers; StAR lysate, positive control.
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Figure 3. (A) Photographs showing the representative immunofluorescent staining of caspase-3 (FITC; green staining) in the
seminiferous tubules of the control and treated groups. (B and C) Immuno-western blotting analysis of caspase-3 protein
expression in testicular lysates of the control and treated groups. BSA, bovine serum albumin (used as the negative control);
a: p < 0.05 (compared with the control group); b: p < 0.05 (compared with the MTX group); IS, interstitial space; ST, seminiferous
tubule; arrows, caspase-3 positive; arrowheads, nucleus. 400X magnification.
Figure 4. Graph showing the representative testicular MDA levels of the control and treated groups. Data are shown as Means ±
SD. a: p < 0.05 (compared with the control group); b: p < 0.05 (compared with the MTX group).
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4. Discussion
Chemotherapeutic agents have adverse effects
on the male reproductive system, depending on
the type and dosage of the drug used, and
typically affect seminiferous epithelial cells
(4). MTX is known as a low-risk gonadotoxic
chemotherapeutic agent that affects the cell
cycle via DNA and RNA synthesis inhibition,
the inhibition of mitosis, and the deamination
of proteins (26). In the present study, MTX was
found to decrease the absolute testicular weight,
the caudal epididymal sperm concentration,
and the diameter of STs. These findings are
supported by results from previous reports (14,
15, 27). In the present study, the significant
decrease in testicular weight in the MTX
group was correlated with the reduction of
seminiferous epithelial height and diameter.
This effect may have been caused by the
increase in caspase-3 expression (Figure 3); our
results thus indicate that MTX induces testicular
apoptosis.
Our study further supports previous research
that has shown the anti-inflammatory effect
of melatonin via the nuclear factor erythroid
2-related factor 2 and nuclear factor kappa-light-
chain-enhancer of activated B cell pathways in rat
testes treated with MTX (28). Melatonin is further
known to possess antioxidant capacities that can
protect testicular injury in many animal models
(29-31). In the present study, a significant decrease
in sperm count was also associated with the
histopathologies found in the testicular and caudal
epididymis tissues. It should be obvious that MTX
caused a reduction in seminiferous diameter
and sperm mass within the epididymal lumen.
These results might be due to the sensitivity
of the mitotic rate of germinal epithelium to
anticancer treatments (32). Although the level of
testosterone in this study was not determined,
the expression of the StAR protein revealed by
western blotting showed no significant difference
among the control and treated groups. Therefore,
MTX may cause damage to the seminiferous
epithelium via another mechanism, such as
oxidative stress. In particular, the adverse effects
of MTX may be caused by ROS, which create
an imbalance between ROS production and
antioxidant defense (33). The significantly
increased testicular caspase-3 expression in
the MTX group is consistent with an increase
in mRNA expression reported by Sheikhbahaei
and coworkers (34). In the present study, MTX
significantly increased the testicular MDA level,
which has also been reported previously (35,
36).
The antioxidant system in the testes consists of
a number of antioxidant enzymes, including SOD,
CAT, and GPX, as well as non-enzyme factors,
such as vitamin C, vitamin E, and melatonin.
Melatonin can regulate normal testicular function
(17, 18). Moreover, it has anti-inflammatory,
proliferative, and ROS scavenging effects (18,
19). Herein, we revealed that melatonin could
reduce testicular damage in the melatonin group,
a finding similar to that made by Wang and
co-workers (36). In the present study, it was
demonstrated for the first time that melatonin
may protect testicular apoptosis by decreasing
caspase-3 expression. However, the MDA level
was increased significantly in the preventive
groups, which is not in concordance with
the results of some previous reports (37).
We assumed that the melatonin dose used
in this study for the stimulation of neuronal
progenitor cell survival had no effect on MDA
reduction (24). Tyrosine phosphorylation in
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the testes is essential for spermatogenesis,
and pattern changes are associated with
increased sperm concentration (4, 14, 38, 39).
The increased expression of the tyrosine-
phosphorylated protein at 31 and 32 kDa in
the MTX-treated testes is similar to that reported
by Iamsaard et al. (14). In addition, the expression
of tyrosine-phosphorylated protein at 47 kDa
was increased significantly in the melatonin
groups compared with the MTX group. It is
possible that this improvement in tyrosine-
phosphorylated protein expression caused by
melatonin treatment plays an important role in
normal spermatogenesis.
5. Conclusion
Our results indicate that melatonin can increase
seminiferous morphometry and epididymal sperm
concentration. However, the testicular MDA
levels in co-treated groups were not improved.
Melatonin also reduces testicular caspase-3
expression and increases the expression of
tyrosine-phosphorylated proteins in rats treated
with MTX.
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